Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
180.5 NOK | -2.17% | -9.30% | -15.65% |
Apr. 25 | Transcript : Medistim ASA, Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 24 | Medistim ASA Approves Dividend for the Year 2023, Payable on May 6, 2024 | CI |
Sales 2024 * | 539M 50.29M | Sales 2025 * | 563M 52.59M | Capitalization | 3.31B 309M |
---|---|---|---|---|---|
Net income 2024 * | 107M 9.99M | Net income 2025 * | 118M 11.02M | EV / Sales 2024 * | 5.99 x |
Net cash position 2024 * | 78M 7.28M | Net cash position 2025 * | 119M 11.11M | EV / Sales 2025 * | 5.66 x |
P/E ratio 2024 * |
30.8
x | P/E ratio 2025 * |
28
x | Employees | 151 |
Yield 2024 * |
2.49% | Yield 2025 * |
1.87% | Free-Float | 74.38% |
Latest transcript on Medistim ASA
1 day | -2.17% | ||
1 week | -9.30% | ||
Current month | -9.30% | ||
1 month | +1.69% | ||
3 months | -3.73% | ||
6 months | -10.64% | ||
Current year | -15.65% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 09-08-31 | |
Director of Finance/CFO | - | 00-12-31 | |
Anne Waaler
CTO | Chief Tech/Sci/R&D Officer | 68 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 76 | 99-12-31 | |
Director/Board Member | 54 | 23-03-31 | |
Lars Rønn
BRD | Director/Board Member | 60 | 09-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 180.5 | -2.17% | 30,711 |
24-06-06 | 184.5 | -2.89% | 627 |
24-06-05 | 190 | 0.00% | 76 |
24-06-04 | 190 | -0.52% | 1,222 |
24-06-03 | 191 | -4.02% | 1,297 |
Real-time Oslo Bors, June 07, 2024 at 10:45 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.65% | 309M | |
+9.48% | 222B | |
+13.72% | 195B | |
+23.79% | 148B | |
+33.39% | 113B | |
+4.75% | 66.45B | |
+15.59% | 53.11B | |
+3.16% | 50.03B | |
-4.35% | 38.8B | |
-1.27% | 34.85B |
- Stock Market
- Equities
- MEDI Stock